Incyte Corporation

Ian J Forsythe

Henry Yue

Mariah R Baughn

April J A Hafalia

Ameena R Gandhi

Monique G Yao

Yan Lu

Anita Swarnakar

Craig H Ison

Danniel B Nguyen

Vicki S Elliott

Rajagopal Gururajan

Michael B Thornton

Ernestine A Lee

Wen Luo

Shanya D Becha

Soo Yeun Lee

Uyen K Tran

Reena Khare

Thomas W Richardson

Pei Jin

Joseph P Marquis

Narinder K Chawla-Walia

Joana X Li

Amy D Wilson

Olga Bandman

Preeti G Lal

Chandra S Arvizu

Neil Burford

Li Ding

Narinder K Chawla

Yuming Xu

Catherine M Tribouley

Jayalaxmi Ramkumar

Farrah A Khan

Jennifer A Griffin

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Antibodies to human &#x3b2;-adrenergic receptor kinase

Human &#x3b2;-adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Human &#x3b2;-adrenergic receptor kinase nucleic acid molecule

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

Human protein phosphatase 2C

Growing community of inventors

Edmonton, Canada

Ian J Forsythe